glp semaglutide side effects Tirzepatide vs. Semaglutide: What You Should Know Is Ozempic a GLP-1 Medication?

Microdosing Wegovy without professional guidance can lead to inconsistent results, missed safety monitoring, and compounding errors

But Big Food isnt happy

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease (NAFLD), is the most prevalent chronic liver disease worldwide, with an estimated global prevalence of approximately 30%

Across randomized trials, stopping GLP-1/dual incretin therapy is typically followed by clinically meaningful weight regain and loss of cardiometabolic gainsoften within monthshighlighting obesity as a chronic, relapsing condition.

(2) cardiorespiratory fitness (peak oxygen consumption normalized to fat-free mass)

Alternatives to costly Wegovy and Saxenda will make such treatments more widely available worldwide